Clinic Community Manufacturing Presentation 
FDA Law Blog
JANUARY 15, 2024
FDA , Petitioners, a liquid nicotine manufacturer, sued FDA arguing that the Agency was arbitrary and capricious in rejecting the Petitioner’s Premarket Tobacco Application (“PMTA”) in violation of the Administrative Procedure Act (“APA”). FDA also directed manufacturers to produce detailed marketing plans.
GeriPal
JUNE 20, 2024
George 03:01 So I would say that as many clinical issues in older adults, we need to think about them in two ways. Incontinence and avoiding issues can present in an older individual, in some cases, just like they do a younger person. And we can talk about that later in terms of potential clinical implications that may have code.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GeriPal
MAY 8, 2025
We’ll discuss three recent clinical trials involving patients with serious illness, joined by our guests James Downar , Ali John Zarrabi , and Margaret Ross. Alex 00:33 Our next guest is Margaret Ross, who’s a clinical psychologist and researcher at St. Dr. James, welcome to the GeriPal Podcast. James 00:32 Good afternoon.
FDA Law Blog
OCTOBER 17, 2023
If you are developing such products, now may be the time to explore the opportunities presented by the Breakthrough Devices Program. In October 2022, FDA released the draft guidance entitled “Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and Healthcare,” as previously discussed in our blog.
GeriPal
MARCH 24, 2022
But I do think POLST, which I conceptualize as an advance care planning tool, really sits in between those worlds of decisions that are relevant for the present versus the few future. First of all, this does feel primarily like a manufactured controversy. And it I think really highlights how that’s a very blurry line.
FDA Law Blog
MAY 21, 2024
The Attorney General, after considering HHS’ recommendations, “concludes that there is, at present, substantial evidence that marijuana does not warrant control under schedule I.” The Attorney General also released DOJ’s Office of Legal Counsel (“OLC”) opinions providing the rationale and support for the NPRM. NPRM at 44,619. Basis at 24.
Tiny Physician
OCTOBER 17, 2021
Treating with sugar pills : why homeopathic principles are unscientific Arsenicum album lacks evidence from randomized controlled trials Image taken from zeenew.india.com If you take the pain to search “Arsenicum album” in PubMed, you will find hardly 3 clinical trials conducted on this medicine. References 1.
Expert insights. Personalized for you.
115 
Let's personalize your content